TAVR procedure highly effective in aortic valve stenosis

 Friday 9th February 2024 at 4:29 PM

Procedural success rate for TAVR exceeds 95%-Dr. Kapoor 

Ludhiana: 9th February 2024: (Sheeba Singh//Punjab Screen Desk)::

“Transcatheter Aortic Valve Replacement (TAVR) procedure has been proven to be highly effective in treating aortic valve stenosis. TAVR has consistently demonstrated high success rates in treating aortic valve stenosis.”

Addressing a CME on TAVR at a hotel here on Thursday, Punjab Rattan awardee Dr Rajneesh Kapoor said, “According to studies and clinical trials, the procedural success rate for TAVR exceeds 95%. This high success rate can be attributed to the advancements in TAVR technology, including improved valve designs, enhanced imaging, and refined delivery systems,”

Dr. Kapoor mentioned that the patients who undergo TAVR experience significant improvements in symptoms associated with aortic valve stenosis.

Shortness of breath, fatigue, and chest pain, which are common symptoms of the condition, are alleviated after the procedure. Restoring proper blood flow and improving heart function through TAVR leads to an improved quality of life for patients, maintained Dr Kapoor who is chairman interventional cardiology at Medanta Hospitals.

On TAVR associated mortality rates he said that TAVR has been associated with lower mortality rates compared to traditional open-heart surgery, especially in high-risk patients.

Studies have consistently shown that TAVR is non-inferior to surgery in terms of mortality rates, and in some cases, TAVR has demonstrated superior outcomes. This lower mortality rate is attributed to the minimally invasive nature of the procedure and the reduced risk of complications, informed Dr Kapoor.

He further said that one of the advantages of TAVR is its potential to reduce hospital stays compared to open-heart surgery.

The shorter hospitalization period allows patients to recover in the comfort of their own homes sooner. This not only improves patient satisfaction but also reduces healthcare costs associated with prolonged hospital stays, he asserted.

TAVR has been shown to have fewer post-procedural complications compared to traditional open-heart surgery. The reduced risk of infection, bleeding, and other surgical complications contributes to a smoother recovery process for patients, he remarked.

Additionally, the lower incidence of complications minimizes the need for additional interventions, resulting in improved patient outcomes, he said.